Artia Global Partners LP Portfolio
Auto-discovered 13F filer (Top-2000 by latest reported value).
SEC 13F CIK: 0001937964
What is a 13F filing? Who files one and when · What 13F filings can't tell you
Q4 2025 · 50 positions · Total reported value $455.04M · Top-10 concentration 70.7% · Updated 2026-10-18
Last updated: 2026-10-18 · Source: SEC EDGAR Form 13F-HR
Turnover: 44.3% · 13 new · 4 cut · 10 exited
Active Share (vs S&P 500): 98.0% · vs QQQ: 100.0% — share of the book that differs from index weights (higher = more active) · ranking
Est. Qtr Return (Q2 2026 → Q3 2026): -16.4% · vs SPY -18.6% · Prev Value $541.86M — last quarter positions weighted by this quarter price moves · ranking
Est. QTD Return (Q3 2026 → newest close): -2.3% · vs SPY -4.4% · Latest Value $495.64M — latest reported positions valued at quarter-to-date price moves (still in progress) · ranking
In its Q4 2025 13F filing, Artia Global Partners LP disclosed 50 equity positions with a combined reported value of $455.04M. The filing implies a focused portfolio: its ten largest positions account for 70.7% of reported value. HoldingsHub classifies the profile as Small / Focused / Health Tilt / High Turnover.
The largest disclosed positions as of Q4 2025 were INSM ($73.10M), ARGX ($54.41M), LLY ($54.27M). By sector, the heaviest allocations are Health Care 89.2%, Industrials 3.1%. Versus the prior quarter, allocation shifted toward Health Care (+19.5pp), Industrials (+1.4pp) and away from Other (-20.6pp).
Versus the prior quarter, Artia Global Partners LP opened 13 new positions, trimmed 4 and fully exited 10, a turnover rate of 44.3% of positions. The portfolio's overlap with the prior quarter was 46% of names.
The largest new positions opened in Q4 2025 were CDTX ($15.64M), VTYX ($6.28M), PVLA ($6.20M).
Of the 10 positions fully exited versus the prior quarter, the largest were VRNA ($40.44M), MRUS ($27.94M), VRTX ($21.58M).
Figures come from the fund's SEC Form 13F filing. 13F reports are filed within 45 days of quarter end and cover long positions of $100,000 or more; they exclude short positions and non-13F asset classes, so treat this page as a quarter-end snapshot rather than the fund's live book.
New Positions (Q4 2025)
Fully Exited (vs previous quarter)
- VRNA VERONA PHARMA PLC · prev qtr: $40.44M
- MRUS MERUS N V · prev qtr: $27.94M
- VRTX VERTEX PHARMACEUTICALS INC · prev qtr: $21.58M
- BSX BOSTON SCIENTIFIC CORP · prev qtr: $17.89M
- REGN REGENERON PHARMACEUTICALS · prev qtr: $6.00M
- NKTR NEKTAR THERAPEUTICS · prev qtr: $3.30M
- CNTA CENTESSA PHARMACEUTICALS PLC · prev qtr: $3.23M
- TGTX TG THERAPEUTICS INC · prev qtr: $1.97M
Insider Transactions (Form 4)
Latest Artia Global Partners LP buys and sells reported on SEC Form 4 — filed within two business days when the fund's ownership in a stock crosses 10%.
No Form 4 filings for this fund yet — when its ownership in a stock crosses 10%, buys and sells are filed here within two business days.
Fund Profile
Artia Global Partners LP is an SEC-registered 13F filer based in Miami, FL, United States. As of Q2 2026 it reported 48 US equity positions with a combined value of $541.86M. HoldingsHub carries 12 quarters of its filings (Q3 2023–Q2 2026).
Firm Snapshot
- Headquarters: MIAMI, FL, United States
- SEC registration: 801-125942 (status: Approved), registered 2022-06-23
- Regulatory AUM (Form ADV): $778.89M as of 2026-03-31
- Client mix (by RAUM): pension and profit-sharing plans 100%
- Manages 1 private funds, of which 1 hedge funds
Portfolio Structure
- 48 positions · $541.86M reported value (Q2 2026)
- Top 10 holdings = 64.5% of reported value
- Largest position: ABVX (ABIVAX SA) at 12.7%
- Average position size: $11.29M
Sector Tilt
- Health Care 94.9%
- Industrials 2.0%
- (classified holdings cover 97% of value)
Quarterly Activity
- Q2 2026: 7 new, 11 added, 2 reduced, 8 exited
- 28 positions unchanged
Generated from the firm's public SEC Form 13F and ADV filings. It states what the firm has reported — not an evaluation of its strategy, and not investment advice.
| # | Company | Shares | Value | Weight | Allocation | Change |
|---|---|---|---|---|---|---|
| 1 |
|
420.00K | $73.10M | 16.06% | Add | |
| 2 |
|
64.70K | $54.41M | 11.96% | Reduce | |
| 3 |
|
50.50K | $54.27M | 11.93% | Add | |
| 4 |
|
719.37K | $25.31M | 5.56% | Add | |
| 5 |
|
2.01M | $25.21M | 5.54% | Add | |
| 6 |
|
1.02M | $24.49M | 5.38% | Add | |
| 7 |
|
503.94K | $17.68M | 3.88% | Add | |
| 8 |
|
190.75K | $17.54M | 3.85% | Hold | |
| 9 |
|
70.82K | $15.64M | 3.44% | New | |
| 10 |
|
767.10K | $14.01M | 3.08% | Add | |
| 11 |
|
144.38K | $11.42M | 2.51% | Add | |
| 12 |
|
205.09K | $8.45M | 1.86% | Add | |
| 13 |
|
104.19K | $8.30M | 1.82% | Hold | |
| 14 |
|
40.82K | $7.08M | 1.56% | Reduce | |
| 15 |
|
17.40K | $6.92M | 1.52% | Reduce | |
| 16 |
|
695.98K | $6.28M | 1.38% | New | |
| 17 |
|
59.20K | $6.20M | 1.36% | New | |
| 18 |
|
100.00K | $5.55M | 1.22% | Reduce | |
| 19 |
|
137.80K | $5.00M | 1.10% | Add | |
| 20 |
|
119.74K | $4.93M | 1.08% | New | |
| 21 |
|
1.99M | $4.68M | 1.03% | New | |
| 22 |
|
60.10K | $4.34M | 0.95% | Reduce | |
| 23 |
|
96.28K | $4.24M | 0.93% | Hold | |
| 24 |
|
138.51K | $4.20M | 0.92% | Add | |
| 25 |
|
1.84M | $4.12M | 0.91% | New | |
| 26 |
|
17.74K | $3.78M | 0.83% | Add | |
| 27 |
|
14.50K | $3.31M | 0.73% | Hold | |
| 28 |
|
17.99K | $2.88M | 0.63% | New | |
| 29 |
|
129.80K | $2.82M | 0.62% | New | |
| 30 |
|
70.70K | $2.70M | 0.59% | Add | |
| 31 |
|
33.41K | $2.61M | 0.57% | New | |
| 32 |
|
5.00K | $2.44M | 0.54% | Hold | |
| 33 |
|
50.00K | $2.31M | 0.51% | Reduce | |
| 34 |
|
22.95K | $2.00M | 0.44% | Hold | |
| 35 |
|
68.65K | $1.86M | 0.41% | New | |
| 36 |
|
40.00K | $1.79M | 0.39% | Hold | |
| 37 |
|
20.40K | $1.56M | 0.34% | Hold | |
| 38 |
|
41.60K | $1.56M | 0.34% | Hold | |
| 39 |
|
205.32K | $1.34M | 0.29% | New | |
| 40 |
|
9.90K | $1.34M | 0.29% | Reduce | |
| 41 |
|
12.90K | $1.29M | 0.28% | New | |
| 42 |
|
29.20K | $1.20M | 0.27% | Hold | |
| 43 |
|
85.20K | $1.03M | 0.23% | Reduce | |
| 44 |
|
8.10K | $814.78K | 0.18% | New | |
| 45 |
|
41.57K | $754.91K | 0.17% | New | |
| 46 |
|
2.50K | $736.85K | 0.16% | New | |
| 47 |
|
29.19K | $519.62K | 0.11% | New | |
| 48 |
|
42.08K | $512.96K | 0.11% | New | |
| 49 |
|
17.02K | $475.85K | 0.10% | New | |
| 50 |
|
8.76K | $26.97K | 0.01% | New | |
FAQ
What did Artia Global Partners LP buy in 2025-Q4?
In its 2025-Q4 13F filing, Artia Global Partners LP reported 50 equity positions worth $455.04M in aggregate; its largest disclosed positions were INSM ($73.10M), ARGX ($54.41M), LLY ($54.27M).
How large is Artia Global Partners LP's portfolio?
Artia Global Partners LP reported $455.04M of long equity holdings across 50 positions as of 2025-Q4. Top-10 holdings account for 70.7% of reported value.
What is Artia Global Partners LP's investment style?
HoldingsHub classifies the portfolio as Small / Focused / Health Tilt / High Turnover, computed from size, concentration, sector tilt and turnover.
Where does this data come from?
All figures are computed from the fund's SEC Form 13F quarterly filing, which must be filed within 45 days of quarter end for long positions of $100,000 or more.